ProShares UltraShort Nasdaq Biotech (BIS)
-NasdaqGM 37.82 
0.32(0.85%) 12:35PM EDT - Nasdaq Real Time Price
| Prev Close: | 37.50 |
|---|
| Open: | 37.52 |
|---|
| Bid: | 37.74 x 500 |
|---|
| Ask: | 37.96 x 700 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 37.44 - 39.19 |
|---|
| 52wk Range: | 34.00 - 85.52 |
|---|
| Volume: | 3,519 |
|---|
| Avg Vol (3m): | 8,128 |
|---|
| Market Cap: | N/A |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- NASDAQ OMX Global Indexes Announces Methodology Changes to the NASDAQ Biotechnology IndexGlobeNewswire(Mon, Jun 10)
- ProShares Launches New High Yield Bond ETF with Built-In Interest Rate HedgeBusiness Wire(Thu, May 23)
- ETF Inflows/Outflows: UVXY, FEFN, EWC, BISat Forbes(Thu, May 9)
- Proshares UltraShort Nasdaq Biotechnology (BIS) Enters Oversold Territoryat TheStreet(Tue, Apr 16)
- ProShares Launches Listed Private Equity ETFBusiness Wire(Thu, Feb 28)
- ProShares Lowers Net Expense Ratio for CSM, a Morningstar Rated 5-Star ETFBusiness Wire(Thu, Feb 7)
- Commodity Prices Continue To Be A Key Issueat Seeking Alpha(Wed, Jan 16)
- BIS: Large Outflows Detected at ETFat Forbes(Thu, Jan 10)
- ProShares Launches First True Merger Arbitrage ETFBusiness Wire(Thu, Dec 13)
- ProShares Announces Zero Capital Gain Distributions for its 117 Equity and Fixed Income ETFsBusiness Wire(Thu, Nov 29)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|